Global Information
회사소개 | 문의 | 위시리스트

세계의 줄기세포 시장 예측

GLOBAL STEM CELL MARKET FORECAST 2019-2027

리서치사 Inkwood Research
발행일 2019년 07월 상품 코드 484190
페이지 정보 영문 239 Pages
가격
US $ 2,500 ₩ 3,055,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 되지 않으며, 인쇄 또한 불가능합니다.
US $ 3,000 ₩ 3,666,000 PDF (Multi User License) help
동일 사업장(소재지) 내 5명까지 이용가능한 라이센스입니다. PDF 파일은 Copy & Paste가 되지 않습니다. 인쇄는 1명당 1회에 한해 가능하며 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,500 ₩ 5,499,000 PDF (Enterprisewide License) help
동일 기업 및 100% 자회사의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 줄기세포 시장 예측 GLOBAL STEM CELL MARKET FORECAST 2019-2027
발행일 : 2019년 07월 페이지 정보 : 영문 239 Pages

세계의 줄기세포(Stem Cell) 시장에 대해 분석했으며, 시장의 기본적 구조와 시장 성장에 대한 각종 영향요인, 시장 동향과 향후 전망, 제품·기술·용도·지역별 동향, 경쟁 구도, 시장 발전 방향성, 주요 기업 개요 등의 정보를 전해드립니다.

제1장 조사 범위

제2장 조사 방법

제3장 주요 요약

제4장 시장 결정요인

  • 성장 촉진요인
  • 성장 저해요인
  • 시장 기회
  • 시장이 해결해야 할 과제

제5장 세계의 줄기세포 시장 : 시장 세분화

  • 제품별
    • 성체줄기세포
    • 인간배아줄기세포
    • 유도만능줄기세포
    • 쥐신경줄기세포
  • 기술별
    • 줄기세포 획득
      • 조혈모세포(HSC)
      • 줄기세포 성분채집
      • 제대혈줄기세포
    • 줄기세포 생산
      • 치료용 복제
      • 체외수정 줄기세포
      • 줄기세포 배양
    • 줄기세포 동결 보존
    • 줄기세포 증식과 2차 배양
  • 용도별
    • 줄기세포 재생 의료
    • Drug Discovery And Development

제6장 시장 분석

  • Porter's Five Forces 분석
  • PESTEL 분석
  • 밸류체인 분석
  • 시장 기회 매트릭스
  • 구매 기준
  • 전략 제안과 결론
  • 벤더 개요

제7장 지역 분석

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 프랑스
    • 독일
    • 스페인
    • 이탈리아
    • 기타
  • 아시아태평양 지역
    • 인도
    • 중국
    • 일본
    • 한국
    • 기타
  • 기타 지역
    • 라틴아메리카
    • 중동 및 북아프리카
    • 아프리카

제8장 경쟁 구도

  • 시장 점유율 분석

제9장 기업 개요

KSM 17.04.21

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

LIST OF TABLES

  • TABLE 1 GLOBAL STEM CELL MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 2 GLOBAL STEM CELL MARKET BY PRODUCT 2019-2027 ($ MILLION)
  • TABLE 3 GLOBAL STEM CELL MARKET IN ADULT STEM CELL BY REGION 2019-2027 ($ MILLION)
  • TABLE 4 GLOBAL ADULT STEM CELL MARKET BY TYPE 2019-2027 ($ MILLION)
  • TABLE 5 GLOBAL HEMATOPOIETIC STEM CELL MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 6 GLOBAL MESENCHYMAL STEM CELL MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 7 GLOBAL NEURAL STEM CELL MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 8 GLOBAL DENTAL STEM CELL MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 9 GLOBAL UMBILICAL CORD STEM CELL MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 10 GLOBAL HUMAN EMBRYONIC STEM CELL MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 11 GLOBAL INDUCED PLURIPOTENT STEM CELL MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 12 GLOBAL RAT NEURAL STEM CELL MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 13 GLOBAL STEM CELL MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
  • TABLE 14 GLOBAL STEM CELL ACQUISITION MARKET BY TYPE 2019-2027 ($ MILLION)
  • TABLE 15 GLOBAL STEM CELL ACQUISITION MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 16 GLOBAL STEM CELL BONE MARROW MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 17 GLOBAL STEM CELL APHERESIS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 18 GLOBAL UMBILICAL CORD BLOOD MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 19 GLOBAL STEM CELL PRODUCTION MARKET BY TYPE 2019-2027 ($ MILLION)
  • TABLE 20 GLOBAL STEM CELL PRODUCTION MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 21 GLOBAL THERAPEUTIC CLONING MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 22 GLOBAL IVF STEM CELL MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 23 GLOBAL STEM CELL CULTURE MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 24 GLOBAL STEM CELL CRYOPRESERVATION MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 25 GLOBAL STEM CELL EXPANSION AND SUB-CULTURE MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 26 GLOBAL STEM CELL MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 27 GLOBAL REGENERATIVE MEDICINE MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 28 GLOBAL DRUG DISCOVERY AND DEVELOPMENT MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 29 GLOBAL STEM CELL MARKET BY THERAPEUTIC APPLICATION 2019-2027 ($ MILLION)
  • TABLE 30 GLOBAL NEUROLOGICAL DISORDERS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 31 GLOBAL ORTHOPEDIC TREATMENTS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 32 GLOBAL ONCOLOGY DISORDERS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 33 GLOBAL DIABETES MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 34 GLOBAL INJURIES AND WOUNDS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 35 GLOBAL CARDIOVASCULAR DISORDERS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 36 GLOBAL OTHER THERAPEUTIC APPLICATIONS BACK BY REGION 2019-2027 ($ MILLION)
  • TABLE 37 GLOBAL STEM CELL MARKET BY TREATMENT TYPE 2019-2027 ($ MILLION)
  • TABLE 38 GLOBAL ALLOGENEIC STEM CELL THERAPY MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 39 GLOBAL AUTOLOGIC STEM CELL THERAPY MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 40 GLOBAL SYNGENEIC STEM CELL THERAPY MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 41 GLOBAL STEM CELL MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 42 NORTH AMERICA STEM CELL MARKET BY COUNTRY 2019-2027 (IN $ MILLION)
  • TABLE 43 EUROPE STEM CELL MARKET BY COUNTRY 2019-2027 (IN $ MILLION)
  • TABLE 44 ASIA PACIFIC STEM CELL MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 45 STEM CELL RESEARCH POLICIES IN SOME ASIAN COUNTRIES
  • TABLE 46 REST OF WORLD STEM CELL MARKET BY REGION 2019-2027 ($ MILLION)

LIST OF FIGURES

  • FIGURE 1 GLOBAL STEM CELL MARKET 2019-2027 ($ MILLION)
  • FIGURE 2 GLOBAL ADULT STEM CELL MARKET BY REGION 2019-2027 ($ MILLION)
  • FIGURE 3 GLOBAL ADULT STEM CELL MARKET BY HEMATOPOIETIC STEM CELL 2019-2027 ($ MILLION)
  • FIGURE 4 GLOBAL ADULT STEM CELL MARKET BY MESENCHYMAL STEM CELL 2019-2027 ($ MILLION)
  • FIGURE 5 GLOBAL ADULT STEM CELL MARKET BY NEURAL STEM CELL 2019-2027 ($ MILLION)
  • FIGURE 6 GLOBAL ADULT STEM CELL MARKET BY DENTAL STEM CELL 2019-2027 ($ MILLION)
  • FIGURE 7 GLOBAL ADULT STEM CELL MARKET BY UMBILICAL CORD STEM CELL 2019-2027 ($ MILLION)
  • FIGURE 8 GLOBAL STEM CELL MARKET BY HUMAN EMBRYONIC STEM CELL 2019-2027 ($ MILLION)
  • FIGURE 9 GLOBAL STEM CELL MARKET BY INDUCED PLURIPOTENT STEM CELL 2019-2027 ($ MILLION)
  • FIGURE 10 GLOBAL STEM CELL MARKET BY RAT NEURAL STEM CELL 2019-2027 ($ MILLION)
  • FIGURE 11 GLOBAL STEM CELL MARKET BY ACQUISITION 2019-2027 ($ MILLION)
  • FIGURE 12 GLOBAL STEM CELL ACQUISITION MARKET BY BONE MARROW 2019-2027 ($ MILLION)
  • FIGURE 13 GLOBAL STEM CELL ACQUISITION MARKET BY CELL APHERESIS 2019-2027 ($ MILLION)
  • FIGURE 14 GLOBAL STEM CELL ACQUISITION MARKET BY UMBILICAL CORD BLOOD 2019-2027 ($ MILLION)
  • FIGURE 15 GLOBAL STEM CELL MARKET BY PRODUCTION 2019-2027 ($ MILLION)
  • FIGURE 16 GLOBAL STEM CELL PRODUCTION MARKET BY THERAPEUTIC CLONING 2019-2027 ($ MILLION)
  • FIGURE 17 GLOBAL STEM CELL PRODUCTION MARKET BY IVF STEM CELL 2019-2027 ($ MILLION)
  • FIGURE 18 GLOBAL STEM CELL PRODUCTION MARKET BY STEM CELL CULTURE 2019-2027 ($ MILLION)
  • FIGURE 19 GLOBAL STEM CELL MARKET BY STEM CELL CRYOPRESERVATION 2019-2027 ($ MILLION)
  • FIGURE 20 GLOBAL STEM CELL MARKET BY STEM CELL EXPANSION AND SUB-CULTURE 2019-2027 ($ MILLION)
  • FIGURE 21 GLOBAL STEM CELL MARKET BY REGENERATIVE MEDICINE 2019-2027 ($ MILLION)
  • FIGURE 22 GLOBAL STEM CELL MARKET BY DRUG DISCOVERY AND DEVELOPMENT 2019-2027 ($ MILLION)
  • FIGURE 23 GLOBAL STEM CELL MARKET BY NEUROLOGICAL DISORDERS 2019-2027 ($ MILLION)
  • FIGURE 24 GLOBAL STEM CELL MARKET BY ORTHOPEDIC TREATMENTS 2019-2027 ($ MILLION)
  • FIGURE 25 GLOBAL STEM CELL MARKET BY ONCOLOGY DISORDERS 2019-2027 ($ MILLION)
  • FIGURE 26 GLOBAL STEM CELL MARKET BY DIABETES 2019-2027 ($ MILLION)
  • FIGURE 27 GLOBAL STEM CELL MARKET BY INJURIES AND WOUNDS 2019-2027 ($ MILLION)
  • FIGURE 28 GLOBAL STEM CELL MARKET BY CARDIOVASCULAR DISORDERS 2019-2027 ($ MILLION)
  • FIGURE 29 GLOBAL STEM CELL MARKET BY OTHER THERAPEUTIC APPLICATIONS 2019-2027 ($ MILLION)
  • FIGURE 30 GLOBAL STEM CELL MARKET BY ALLOGENEIC STEM CELL THERAPY 2019-2027 ($ MILLION)
  • FIGURE 31 GLOBAL STEM CELL MARKET BY AUTOLOGIC STEM CELL THERAPY 2019-2027 ($ MILLION)
  • FIGURE 32 GLOBAL STEM CELL MARKET BY SYNGENEIC STEM CELL THERAPY 2019-2027 ($ MILLION)
  • FIGURE 33 GLOBAL STEM CELL MARKET SHARE BY REGION 2019-2027 (%)
  • FIGURE 34 THE UNITED STATES STEM CELL MARKET 2019-2027 (IN $ MILLION)
  • FIGURE 35 CANADA STEM CELL MARKET 2019-2027 (IN $ MILLION)
  • FIGURE 36 THE UNITED KINGDOM STEM CELL MARKET 2019-2027 (IN $ MILLION)
  • FIGURE 37 FRANCE STEM CELL MARKET 2019-2027 (IN $ MILLION)
  • FIGURE 38 GERMANY STEM CELL MARKET 2019-2027 (IN $ MILLION)
  • FIGURE 39 SPAIN STEM CELL MARKET 2019-2027 (IN $ MILLION)
  • FIGURE 40 ITALY STEM CELL MARKET 2019-2027 (IN $ MILLION)
  • FIGURE 41 REST OF EUROPE STEM CELL MARKET 2019-2027 (IN $ MILLION)
  • FIGURE 42 ASIA PACIFIC STEM CELL MARKET 2019-2027 ($ MILLION)
  • FIGURE 43 INDIA STEM CELL MARKET 2019-2027 ($ MILLION)
  • FIGURE 44 CHINA STEM CELL MARKET 2019-2027($ MILLION)
  • FIGURE 45 JAPAN STEM CELL MARKET 2019-2027 ($ MILLION)
  • FIGURE 46 AUSTRALIA STEM CELL MARKET 2019-2027 ($ MILLION)
  • FIGURE 47 SOUTH KOREA STEM CELL MARKET 2019-2027 ($ MILLION)
  • FIGURE 48 REST OF APAC STEM CELL MARKET 2019-2027($ MILLION)
  • FIGURE 49 REST OF WORLD STEM CELL MARKET 2019-2027 ($ MILLION)
  • FIGURE 50 LATIN AMERICA STEM CELL MARKET 2019-2027 ($ MILLION)
  • FIGURE 51 MIDDLE EAST & AFRICA STEM CELL MARKET 2019-2027 ($ MILLION)
  • FIGURE 52 STEM CELL MARKET SHARE ANALYSIS OF KEY PLAYERS 2018 (%)

KEY FINDINGS

The global stem cell market is anticipated to expand at a CAGR of 9.50% during the forecast period of 2019-2027. The role of stem cells in the development of the regenerative medicine and treatment, and the important implementation of stem cell therapies for anti-aging and extending lifespan are contributing to the market growth for stem cell.

MARKET INSIGHTS

The global stem cell market is segmented on the basis of product, technology, application therapeutic, application, and treatment type, and geography. Safety issues and ethical issues have been limiting the growth for stem cell market. The safety issues regarding the storage of stem cells in the gene banks are required to be further clarified for reducing the immense exploitation of stem cell therapy. The growth in the stem cell applications market has been mostly influenced by the introduction of the regenerative medicines.

REGIONAL INSIGHTS

The stem cell market geography is segmented into North America, Europe, Asia-Pacific and the Rest of World. The stem cell market in North America is expected to hold the largest share by 2027. The rising number of the cancer cases in the region have mainly contributed to the growth of the market in the North American region. Asia Pacific is anticipated to grow with the fastest CAGR over the forecast period. The growth of the Asia Pacific region is primarily driven by the growing incidences of chronic lifestyle diseases, and the huge investments in medical research and healthcare facilities. On the other hand, the Europe stem cell analysis market is primarily driven by the rising prevalence of chronic disorders and the citizen's changing lifestyles.

COMPETITIVE INSIGHTS

Corning Inc., Fibrocell Science Inc., Cytori Therapeutics, Brainstorm Cell Therapeutics, Thermo Fisher, Vericel Corporation (formerly Aastrom Bioscience), Becton Dickinson And Company, Takara Holdings Inc., Stryker Corporation, Biotime Inc., Cellular Engineering Technologies, Inc., StemCell Technologies, International Stem Cell Corp., Celgene Corporation, Cellular Dynamics International (Holding Company Fujifilm), GE Healthcare, Pluristem Therapeutics Inc., Qiagen N.V., and Stemedica Cell Technologies Inc. are the major companies operating in the market.

Table of contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP-DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION
  • 2.5. ESTIMATION METHODOLOGY

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. REGENERATIVE MEDICINE IS THE EMERGING BRANCH OF MEDICAL SCIENCE
    • 3.2.2. USE OF ADULT STEM CELL HAS BEEN SIGNIFICANT
    • 3.2.3. INDUCED PLURIPOTENT IS THE FASTEST GROWING STEM CELL PRODUCT
    • 3.2.4. STEM CELL ACQUISITION IS THE HIGHEST REVENUE GENERATING TECHNOLOGY SEGMENT
    • 3.2.5. ORTHOPEDIC TREATMENTS IS THE WIDELY USED STEM CELL THERAPEUTIC APPLICATION
    • 3.2.6. AUTOLOGIC STEM CELL THERAPY TREATMENT TYPE IS ANTICIPATED TO GROW SIGNIFICANTLY OVER THE FORECAST PERIOD

4. MARKET DYNAMICS

  • 4.1. MARKET SCOPE & DEFINITION
  • 4.2. MARKET DRIVER
    • 4.2.1. POTENTIAL OF STEM CELL IN REGENERATIVE MEDICINE
    • 4.2.2. KEY TO ANTI-AGEING AND PROLONGING LIFE
    • 4.2.3. INCREASING R&D INVESTMENTS IN ADULT STEM CELL RESEARCH
    • 4.2.4. EASE OF ADMINISTRATION
    • 4.2.5. REDUCED RISK OF TISSUE REJECTION IN TRANSPLANTS
    • 4.2.6. FEDERAL FUNDING FOR STEM CELL RESEARCH
    • 4.2.7. RISING AWARENESS ABOUT UMBILICAL CORD STEM CELL
    • 4.2.8. RISING NUMBER OF CLINICAL TRIALS ASSOCIATED WITH STEM CELL RESEARCH
  • 4.3. MARKET RESTRAINTS
    • 4.3.1. SAFETY ISSUES
    • 4.3.2. ETHICAL ISSUES
    • 4.3.3. HIGH COST ASSOCIATED WITH STEM CELL PROCEDURES
  • 4.4. MARKET OPPORTUNITIES
    • 4.4.1. TECHNOLOGICAL INNOVATIONS
    • 4.4.2. EMERGING APPLICATION AS A DRUG DISCOVERY TOOL
    • 4.4.3. OTHER PROMISING APPLICATIONS
  • 4.5. MARKET CHALLENGES
    • 4.5.1. STRINGENT GOVERNMENT REGULATIONS
    • 4.5.2. LESS RESPONSIVENESS IN THE DEVELOPED ECONOMIES
    • 4.5.3. LACK OF LEGISLATION

5. MARKET BY PRODUCTS

  • 5.1. ADULT STEM CELL MARKET
    • 5.1.1. HEMATOPOIETIC STEM CELL MARKET
    • 5.1.2. MESENCHYMAL STEM CELL MARKET
    • 5.1.3. NEURAL STEM CELL MARKET
    • 5.1.4. DENTAL STEM CELL MARKET
    • 5.1.5. UMBILICAL CORD STEM CELL MARKET
  • 5.2. HUMAN EMBRYONIC STEM CELL
  • 5.3. INDUCED PLURIPOTENT STEM CELL MARKET
  • 5.4. RAT NEURAL STEM CELL MARKET

6. MARKET BY TECHNOLOGY

  • 6.1. STEM CELL ACQUISITION
    • 6.1.1. STEM CELL BONE MARROW MARKET
    • 6.1.2. STEM CELL APHERESIS MARKET
    • 6.1.3. UMBILICAL CORD BLOOD MARKET
  • 6.2. STEM CELL PRODUCTION
    • 6.2.1. THERAPEUTIC CLONING
    • 6.2.2. IVF STEM CELL
    • 6.2.3. STEM CELL CULTURE
  • 6.3. STEM CELL CRYOPRESERVATION
  • 6.4. STEM CELL EXPANSION AND SUB-CULTURE

7. MARKET BY APPLICATION

  • 7.1. REGENERATIVE MEDICINE
  • 7.2. DRUG DISCOVERY AND DEVELOPMENT

8. MARKET BY THERAPEUTIC APPLICATION

  • 8.1. NEUROLOGICAL DISORDERS
  • 8.2. ORTHOPEDIC TREATMENTS
  • 8.3. ONCOLOGY DISORDERS
  • 8.4. DIABETES
  • 8.5. INJURIES AND WOUNDS
  • 8.6. CARDIOVASCULAR DISORDERS
  • 8.7. OTHER THERAPEUTIC APPLICATIONS

9. MARKET BY TREATMENT TYPE

  • 9.1. ALLOGENEIC STEM CELL THERAPY
  • 9.2. AUTOLOGIC STEM CELL THERAPY
  • 9.3. SYNGENEIC STEM CELL THERAPY

10. KEY ANALYTICS

  • 10.1. PORTER'S FIVE FORCES ANALYSIS
    • 10.1.1. THREAT OF NEW ENTRANTS
    • 10.1.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
    • 10.1.3. BARGAINING POWER OF BUYER
    • 10.1.4. BARGAINING POWER OF SUPPLIER
    • 10.1.5. INTENSITY OF COMPETITIVE RIVALRY
  • 10.2. VALUE CHAIN ANALYSIS
  • 10.3. OPPORTUNITY MATRIX
  • 10.4. KEY BUYING CRITERIA
    • 10.4.1. HIGH PRICE
    • 10.4.2. EFFICACY
    • 10.4.3. APPLICATION AND EFFECTIVENESS
    • 10.4.4. ACCURACY
  • 10.5. STRATEGIC RECOMMENDATION & STRATEGIC CONCLUSIONS
  • 10.6. PEST ANALYSIS
  • 10.7. HISTORY OF STEM CELL
  • 10.8. PATENT ANALYSIS
    • 10.8.1. STEM CELL PATENT IN NORTH AMERICA
    • 10.8.2. STEM CELL PATENT IN EUROPE
    • 10.8.3. STEM CELL PATENT IN ASIA PACIFIC
  • 10.9. REGULATORY FRAMEWORK

11. GEOGRAPHICAL ANALYSIS

  • 11.1. NORTH AMERICA
    • 11.1.1. THE UNITED STATES
    • 11.1.2. CANADA
  • 11.2. EUROPE
    • 11.2.1. THE UNITED KINGDOM
    • 11.2.2. FRANCE
    • 11.2.3. GERMANY
    • 11.2.4. SPAIN
    • 11.2.5. ITALY
    • 11.2.6. REST OF EUROPE
  • 11.3. ASIA PACIFIC (APAC)
    • 11.3.1. INDIA
    • 11.3.2. CHINA
    • 11.3.3. JAPAN
    • 11.3.4. AUSTRALIA
    • 11.3.5. SOUTH KOREA
    • 11.3.6. REST OF ASIA PACIFIC
  • 11.4. REST OF WORLD (ROW)
    • 11.4.1. LATIN AMERICA
    • 11.4.2. MIDDLE EAST & AFRICA

12. COMPETITIVE LANDSCAPE

  • 12.1. MARKET SHARE ANALYSIS
  • 12.2. COMPANY PROFILE
    • 12.2.1. BECTON DICKINSON AND COMPANY
    • 12.2.2. BIOTIME INC.
    • 12.2.3. BRAINSTORM CELL THERAPEUTICS
    • 12.2.4. CELGENE CORPORATION
    • 12.2.5. CELLULAR DYNAMICS INTERNATIONAL (HOLDING COMPANY FUJIFILM)
    • 12.2.6. CELLULAR ENGINEERING TECHNOLOGIES, INC.
    • 12.2.7. CORNING INC.
    • 12.2.8. CYTORI THERAPEUTICS
    • 12.2.9. FIBROCELL SCIENCE INC.
    • 12.2.10. GE HEALTHCARE
    • 12.2.11. INTERNATIONAL STEM CELL CORP.
    • 12.2.12. STEMEDICA CELL TECHNOLOGIES INC.
    • 12.2.13. STRYKER CORPORATION
    • 12.2.14. TAKARA HOLDINGS INC.
    • 12.2.15. THERMO FISHER
    • 12.2.16. VERICEL CORPORATION (FORMERLY AASTROM BIOSCIENCE)
    • 12.2.17. PLURISTEM THERAPEUTICS INC.
    • 12.2.18. QIAGEN N.V.
    • 12.2.19. STEMCELL TECHNOLOGIES
Back to Top
전화 문의
F A Q